cutaneous leishmaniasis การใช้

• It is associated with cutaneous leishmaniasis also called " oriental sore ".
• Between August 2002 and February, 522 cases of cutaneous leishmaniasis have been identified.
• About 1.5 million cases of cutaneous leishmaniasis happen each year, the CDC said.
• Cutaneous leishmaniasis has been seen in American and Canadian troops coming back from Afghanistan.
• It is a skin infection caused by a cutaneous leishmaniasis.
• Cutaneous leishmaniasis in North Africa; " Leishmania major " infected areas are in blue
• Most species of " Leishmania " are capable of infecting humans and causing cutaneous leishmaniasis.
• About 1 . 5 million cases of cutaneous leishmaniasis happen each year, the CDC said.
• Cutaneous leishmaniasis occurs in Afghanistan, Algeria, Brazil, Colombia, Iran, Pakistan, Peru, Saudi Arabia, and Syria.
• The disease, cutaneous leishmaniasis, usually affects the skin and can cause serious disability and permanent scarring.
• Cutaneous leishmaniasis can cause lesions anywhere on the body, but most usually appear on exposed parts like the face.
• Cutaneous leishmaniasis, although less dangerous, is still a problem for military personnel in areas like the Middle East and Panama.
• Kabul is estimated as the largest center of cutaneous leishmaniasis in the world, with around 67, 500 cases as of 2004.
• Several infectious diseases broke out in Aleppo and other areas in Syria during the civil war, including poliomyelitis, measles and cutaneous leishmaniasis.
• A number of different treatments have yielded results of varying effectiveness in the treatment of " L . major " caused cutaneous leishmaniasis.
• One reason that the form affecting the skin, cutaneous leishmaniasis, thrives in so many locales worldwide is its large range of reservoir hosts.
• Though a vaccine does not yet exist that can prevent cutaneous leishmaniasis, it is speculated that one will be developed in the near future.
• Afghanistan's capital, Kabul, is now the largest center of cutaneous leishmaniasis in the world, with an estimated 67, 500 cases out of the country's total 200, 000 cases.
• Several medical agents have some efficacy against visceral or cutaneous leishmaniasis, however, a 2005 survey concluded that miltefosine is the only effective oral treatment for both forms of leishmaniasis.
• Dogs and rodents serve as the primary animal reservoir hosts in the sylvatic cycle, but people with chronic PKDL can also serve as important reservoir hosts for cutaneous leishmaniasis.